Moderate Asthma
Also known as: Moderate asthma (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00043 | Omalizumab | A monoclonal anti-immunoglobulin E (IgE) antibody used to treat asthma, chronic idiopathic urticaria, chronic rhinosinusitis with nasal polyps, and IgE-mediated food allergy. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00043 | Omalizumab | High affinity immunoglobulin epsilon receptor subunit alpha | target |
| DB00043 | Omalizumab | High affinity immunoglobulin epsilon receptor subunit beta | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB16206 | Itepekimab | 1 | Completed | 1 |
| DB12169 | Tralokinumab | 1 | Terminated | 1 |
| DB11194 | Pyruvic acid | 1 / 2 | Terminated | 1 |
| DB00736 | Esomeprazole | 3 | Not Yet Recruiting | 1 |
| DB13867 | Fluticasone | 3 | Not Yet Recruiting | 1 |
| DB00983 | Formoterol | 3 | Not Yet Recruiting | 1 |